• Home
  • About IBT
    • Vision and Mission
    • IBT History
    • Management
    • Board of Directors
    • Advisory Board
    • Sustainability Policy
  • Pipeline
    • IBP-9414
    • IBP-1016
    • IBP-1118
    • IBP-1122
  • Families
  • Healthcare Professionals
  • Investors & Media
    • Shares
    • Presentations
    • Share Issue
    • Ownership Structure
    • Corporate Governance
    • Calendar
    • Financial Reports
    • Press Releases
    • News
    • Investors & Media Contact
    • Subscribe
  • Contact Us
  • Career
IBT Logo IBT Logo
  • En
  • Sv
  • Home
  • About IBT
    • Vision and Mission
    • IBT History
    • Management
    • Board of Directors
    • Advisory Board
    • Sustainability Policy
  • Pipeline
    • IBP-9414
    • IBP-1016
    • IBP-1118
    • IBP-1122
  • Families
  • Healthcare Professionals
  • Investors & Media
    • Shares
    • Presentations
    • Share Issue
    • Ownership Structure
    • Corporate Governance
    • Calendar
    • Financial Reports
    • Press Releases
    • News
    • Investors & Media Contact
    • Subscribe
  • Contact Us
  • Career

Press releases


IBT resolves on a rights issue

Read more here

 

 

 

 

 

 

 

 

 

 

 

 

May 16, 2023

Latest press releases

Notice of Extraordinary General Meeting of Infant Bacterial Therapeutics
IBT resolves on a rights issue
Infant Bacterial Therapeutics AB (publ), Interim report January 1-March 31, 2023
Annual General Meeting of Infant Bacterial Therapeutics
Notice of Annual General Meeting of Infant Bacterial Therapeutics
This site uses cookies – small text-based files that are placed on your device to help us provide a better user experience. Find out more.
Contact | info@ibtherapeutics.com
© Copyright Infant Bacterial Therapeutics AB 2023
Cookie Policy Privacy Policy Terms of Use